Glaxo Canada loses transfer pricing case
June 12, 2008
Pharmaceuticals company could face massive tax bill
A ruling in the Tax Court of Canada this week against GlaxoSmithKline Canada could cost the pharmaceuticals company millions of dollars in back taxes, penalties and interest.
Sorry. You must be a subscriber to view this article. Alternatively, why not take a free trial? To subscribe and access this article immediately simply click here or call +44(0)207 779 8380.